Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00159432
What this trial is testing

Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Southern California 63
Not applicableLooking for participantsNCT07353632
What this trial is testing

What Influence Re-participation in the Danish Colorectal Screening Program.

Who this might be right for
ColonoscopyScreening ColonscopyPain
Esbjerg Hospital - University Hospital of Southern Denmark 8,000
Early research (Phase 1)Study completedNCT00183833
What this trial is testing

Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors

Who this might be right for
Colon CancerColorectal Cancer
University of Southern California 40
Not applicableStudy completedNCT02678832
What this trial is testing

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Who this might be right for
Colorectal CancerBreast CancerProstate Cancer+2 more
Heidelberg University 2,200
Testing effectiveness (Phase 2)Study completedNCT01975077
What this trial is testing

A Phase Ib Study of Fruquintinib in 3rd Line mCRC

Who this might be right for
Colorectal Cancer
Hutchison Medipharma Limited 62
Large-scale testing (Phase 3)Study completedNCT00003287
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 554
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Testing effectiveness (Phase 2)UnknownNCT00043199
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 40
Not applicableStudy completedNCT05571098
What this trial is testing

The Effects of Nurse Navigation Program on Symptom Management and Psychosocial Adjustment in Colorectal Cancer Patients

Who this might be right for
Colorectal CancerPsycho-OncologyNursing
Saglik Bilimleri Universitesi 60
Testing effectiveness (Phase 2)Study completedNCT00332163
What this trial is testing

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Who this might be right for
Metastatic Colorectal CancerSkin RashSkin Toxicities+2 more
Amgen 95
Testing effectiveness (Phase 2)Study completedNCT02613221
What this trial is testing

A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 56
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Testing effectiveness (Phase 2)Study completedNCT01640444
What this trial is testing

Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)

Who this might be right for
Colorectal Cancer Metastatic
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 240
Large-scale testing (Phase 3)Active Not RecruitingNCT03869892
What this trial is testing

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 856
Not applicableEnded earlyNCT01881932
What this trial is testing

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

Who this might be right for
Breast CancerColorectal Cancer
University of Maryland, Baltimore 19
Not applicableNo Longer AvailableNCT06195514
What this trial is testing

Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Takeda
Not applicableStudy completedNCT00525655
What this trial is testing

Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)

Who this might be right for
Familial Adenomatous PolyposisColorectal Cancer
M.D. Anderson Cancer Center 31
Not applicableStudy completedNCT05018156
What this trial is testing

Default Genetics Referrals for Young-Onset Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Pennsylvania 53
Testing effectiveness (Phase 2)Looking for participantsNCT07213570
What this trial is testing

STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
National Cancer Institute, Naples 60
Testing effectiveness (Phase 2)Study completedNCT02230553
What this trial is testing

Lapatinib Plus Trametinib in KRAS Mutant NSCLC

Who this might be right for
Colorectal Cancer
The Netherlands Cancer Institute 35
Next Page